BioCorRx Statistics
Want to see BICX full AI Analyst Report?
BioCorRx (BICX) Stock Statistics & Valuation Metrics
Total Valuation
BioCorRx has a market cap or net worth of $6.28M. The enterprise value is $17.35M.
- Market Cap
- $6.28M
- Enterprise Value
- $17.35M
Share Statistics
BioCorRx has 29,758,177 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 29,758,177
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
BioCorRx’s return on equity (ROE) is 0.31 and return on invested capital (ROIC) is 112.37%.
- Return on Equity (ROE)
- 0.31
- Return on Assets (ROA)
- -1.60
- Return on Invested Capital (ROIC)
- 112.37%
- Return on Capital Employed (ROCE)
- 0.78
- Revenue Per Employee
- 265.75K
- Profits Per Employee
- -1.15M
- Employee Count
- 3
- Asset Turnover
- 0.37
- Inventory Turnover
- 0.74
Valuation Ratios
The current PE Ratio of BioCorRx is -4.43. BioCorRx’s PEG ratio is -0.02.
- PE Ratio
- -4.43
- PS Ratio
- 56.09
- PB Ratio
- -0.48
- Price to FCF
- -3.28
- Price to Operating Cash Flow
- -3.31
- PEG Ratio
- -0.02
Income Statement
In the last 12 months, BioCorRx had revenue of 797.24K and earned -3.44M in profits. Earnings per share was -0.19.
- Revenue
- 797.24K
- Gross Profit
- 691.38K
- Operating Income
- -4.83M
- Pretax Income
- -3.51M
- Net Income
- -3.44M
- EBITDA
- -2.60M
- Earnings Per Share (EPS)
- -0.19
Cash Flow
In the last 12 months, operating cash flow was -1.90M and capital expenditures 3, giving a free cash flow of -1.90M billion.
- Operating Cash Flow
- -1.90M
- Free Cash Flow
- -1.90M
- Free Cash Flow per Share
- -0.06
Dividends & Yields
BioCorRx pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -30.51%
- Earnings Yield
- -32.39%
Stock Price Statistics
- Beta
- -0.03
- 52-Week Price Change
- -53.35%
- 50-Day Moving Average
- 0.22
- 200-Day Moving Average
- 0.30
- Relative Strength Index (RSI)
- 47.93
- Average Volume (3m)
- 2,897
Important Dates
BioCorRx upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 17, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
BioCorRx as a current ratio of 0.10, with Debt / Equity ratio of -18.97%
- Current Ratio
- 0.10
- Quick Ratio
- 0.08
- Debt to Market Cap
- 0.37
- Net Debt to EBITDA
- -0.76
- Interest Coverage Ratio
- -5.61
Taxes
In the past 12 months, BioCorRx has paid -68.62K in taxes.
- Income Tax
- -68.62K
- Effective Tax Rate
- 0.02
Enterprise Valuation
BioCorRx EV to EBITDA ratio is -2.27, with an EV/FCF ratio of -4.48.
- EV to Sales
- 76.62
- EV to EBITDA
- -2.27
- EV to Free Cash Flow
- -4.48
- EV to Operating Cash Flow
- -4.48
Balance Sheet
BioCorRx has $18.23K in cash and marketable securities with $2.30M in debt, giving a net cash position of -$2.28M billion.
- Cash & Marketable Securities
- $18.23K
- Total Debt
- $2.30M
- Net Cash
- -$2.28M
- Net Cash Per Share
- -$0.08
- Tangible Book Value Per Share
- -$0.47
Margins
Gross margin is 248.52%, with operating margin of -3915.67%, and net profit margin of -1837.63%.
- Gross Margin
- 248.52%
- Operating Margin
- -3915.67%
- Pretax Margin
- -2830.85%
- Net Profit Margin
- -1837.63%
- EBITDA Margin
- -3375.14%
- EBIT Margin
- -2430.28%
Scores
- Smart Score
- ―
- AI Score
- 43

